Sarepta Therapeutics Stock Price (NASDAQ:SRPT)

Add to My Stocks
$28.68 $0.4 (1.41%) SRPT stock closing price Feb 21, 2017 (Closing)
Sarepta Therapeutics
21 FEB 2017
amigobulls logo
SRPT hand_up
SRPT vs S&P 500
Closing Price: Feb 21, 2017
$28.68 ( 1.41%)
S&P 500
2365.4 ( 0.6%)
52 Week Price Range
1 Year Return: 86.3%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
Pays Dividend ?
12 Months Dividend
  : $0
Dividend Yield
  : -99900%
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Sarepta Therapeutics Snapshot Video

19 5 2

SRPT Stock Details

Prev Close* : $28.28
Market Cap:
Day Low: $28.08
52 Week Low: $8.00
Open: $28.88
Volume: 2139772
Day High: $29
52 Week High: $63.73

Latest Stock Market News

Latest Articles

Sarepta Therapeutics News - From Partners

6 Best Performing Drug Stocks of September   by Zacks on Oct 03, 2016
Company News for September 15, 2016   by Zacks on Sep 15, 2016

SRPT Stockcharts

View SRPT PE ratio, PS ratio stocks charts and compare with peers.
SRPT Chart
Note: Compare Sarepta Therapeutics stock price history with the index and industry peers.

Sarepta Therapeutics Financial Ratios

Debt to Equity

SRPT Industry Peers

Company Price Change (%)
Avexis (AVXS)59.150.21 (0.35%)
Halozyme Therapeutics (HALO)12.510.1 (0.79%)
Aviragen Therapeutics (AVIR)0.70 (0%)
Biocryst Pharma (BCRX)6.10.46 (7.01%)
Gilead Sciences (GILD)69.290.56 (0.8%)
Ptc Therapeutics (PTCT)13.50.66 (4.66%)
Vertex Pharma (VRTX)86.551.78 (2.02%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)22.412.5 (12.56%)
Fate Therapeutics (FATE)4.380.45 (11.45%)
Nymox Pharmaceutical (NYMX)3.540.12 (3.51%)
Myriad Genetics (MYGN)19.080.46 (2.47%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Evogene (EVGN)5.4210.11 (2.07%)
OncoMed Pharma (OMED)8.910.18 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Trevena (TRVN)4.272.86 (40.11%)
Momenta Pharma (MNTA)16.052.95 (15.53%)
Peregrine Pharma (PPHM)0.4790.07 (12.73%)
Cytokinetics (CYTK)10.40.85 (7.56%)
Argos Therapeutics (ARGS)4.40.3 (6.38%)
Sorrento Therapeutics (SRNE)5.250.3 (5.41%)
Immunomedics (IMMU)5.060.28 (5.24%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017

Sarepta Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues1.25M9.75M14.21M37.32M46.99M
Net Income-220.03M-135.78M-111.98M-121.28M-2.31M
Total Operating Expense221.43M143.54M104.49M67.03M82.91M
view Sarepta Therapeutics Inc income statement
balance sheet20152014201320122011
Total Assets273.78M295.03M291.56M204.99M54.36M
Total Liabilities83.43M47.38M44.37M81.31M23.35M
Shareholders Equity190.34M247.65M247.19M123.67M31.01M
view Sarepta Therapeutics Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities31.98M-22.13M12.26M-5.3M6.93M
Net Cash From (Used By) Operating Activities-149.46M-128.53M-64.69M-29.69M-23.67M
Increase (Decrease) In Prop Plant And Equipment-3.4M-25.44M-2.37M-0.1M-1.17M
view Sarepta Therapeutics Inc cashflow statement

Sarepta Therapeutics Inc Stock News - Partner Headlines

Sarepta Therapeutics Stock Message Board

Sarepta Therapeutics stock price ended the last trading day at 28.28. Stock price or share price can be used to find the total market value of a company. Sarepta Therapeutics market cap stands at 1.54B as of 17 Feb, 2017. Sarepta Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Sarepta Therapeutics stock price and Sarepta Therapeutics share price mean the same thing. The volume of shares traded stood at 1406684 on the last trading day, as is evident from Sarepta Therapeutics stock chart, and SRPT stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Sarepta Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.